Search Results - "Hernández‐Garfella, Marisa"

Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study by Atienza-Mateo, Belén, Calvo-Río, Vanesa, Beltrán, Emma, Martínez-Costa, Lucía, Valls-Pascual, Elia, Hernández-Garfella, Marisa, Atanes, Antonio, Cordero-Coma, Miguel, Miquel Nolla, Joan, Carrasco-Cubero, Carmen, Loricera, Javier, González-Vela, María C, Vegas-Revenga, Nuria, Fernández-Díaz, Carlos, Demetrio-Pablo, Rosalía, Domínguez-Casas, Lucía C, Luis Martín-Varillas, José, Palmou-Fontana, Natalia, Hernández, José L, González-Gay, Miguel Á, Blanco, Ricardo

“…Abstract Objective To assess the efficacy of tocilizumab (TCZ) in refractory uveitis of Behçet's disease (BD). Methods Multicentre study of patients with…”
Get full text

Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients by Martín-Varillas, José Luis, Atienza-Mateo, Belén, Calvo-Rio, Vanesa, Beltrán, Emma, Sánchez-Bursón, Juan, Adán, Alfredo, Hernández-Garfella, Marisa, Valls-Pascual, Elia, Sellas-Fernández, Agustí, Ortego, Norberto, Maíz, Olga, Torre, Ignacio, Fernández-Espartero, Cruz, Jovani, Vega, Peiteado, Diana, Valle, David Díaz, Aurrecoechea, Elena, Caracuel, Miguel A, García-González, Alfredo J, Álvarez, Enrique Raya, Vegas-Revenga, Nuria, Demetrio-Pablo, Rosalía, Castañeda, Santos, González-Gay, Miguel A, Hernández, José Luis, Blanco, Ricardo

“…In a large series of White patients with refractory uveitis due to Behçet disease (BD) being treated with infliximab (IFX), we assessed (1) long-term efficacy…”
Get full text

An objective scatter index cutoff point as a powerful objective criterion for preoperative nuclear cataract decision-making based on ROC analysis by Monferrer-Adsuara, Clara, Mata-Moret, Lucía, Castro-Navarro, Verónica, Hernández-Garfella, Marisa, Gracia-García, Alicia, Ortiz-Salvador, Miguel, Remolí-Sargues, Lidia, Cervera-Taulet, Enrique

“…To assess the correlation between clinical cataract surgery indication and the objective scatter index (OSI) by defining the optimal OSI cutoff point in the…”
Get full text

Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients by Barroso-García, Nuria, Atienza-Mateo, Belén, Ferraz-Amaro, Iván, Prieto-Peña, Diana, Beltrán, Emma, Adán, Alfredo, Hernández-Garfella, Marisa, Martínez-Costa, Lucía, Cordero-Coma, Miguel, Díaz-Llopis, Manuel, Herreras, José M., Maíz-Alonso, Olga, Torre-Salaberri, Ignacio, De Vicente-Delmás, Ana, Díaz-Valle, David, Atanes-Sandoval, Antonio, Francisco, Félix, Insua, Santos, Sánchez, Julio, Almodóvar-González, Raquel, Jiménez-Sosa, Alejandro, Ruiz-Moreno, Oscar, Gandía-Martínez, Myriam, Nolla, Joan M., Calvo-Río, Vanesa, Castañeda, Santos, González-Gay, Miguel A., Blanco, Ricardo

“…To compare the efficacy of TNF inhibitors (adalimumab (ADA) and infliximab (IFX)) vs tocilizumab (TCZ) in patients with refractory cystoid macular edema (CME)…”
Get full text

The first case of fungal endogenous endophthalmitis caused by Aspergillus nidulans: Diagnostic and therapeutic challenge by Mata-Moret, Lucia, Monferrer-Adsuara, Clara, Hernández-Bel, Laura, Hernández-Garfella, Marisa, Torrecillas-Muelas, Miriam, Ocete-Mochón, Maria Dolores, Cervera-Taulet, Enrique

“…Significance: Fungal endogenous endophthalmitis is an uncommon and potentially blinding infection. Aspergillus is a causative organism in immunocompromized…”
Get full text

Rare association between Vogt-Koyanagi-Harada disease and rheumatoid arthritis: Report of a clinical case from the unit of multidisciplinary uveitis by Paz-Solarte, Juan Alberto, Hernández-Garfella, Marisa, Rueda-Cid, Amalia, Campos-Fernández, Cristina, Calvo-Catala, Javier

Get full text

Adalimumab therapy for refractory uveitis: a pilot study by Diaz-Llopis, Manuel, García-Delpech, Salvador, Salom, David, Udaondo, Patricia, Hernández-Garfella, Marisa, Bosch-Morell, Francisco, Quijada, Arturo, Romero, Francisco J

“…The aim of this study was to assess the efficacy and safety of adalimumab in treating refractory autoimmune uveitis. This work was a prospective,…”
Get more information

Development of an activity disease score in patients with uveitis (UVEDAI) by Pato, Esperanza, Martin-Martinez, Mª Auxiliadora, Castelló, Adela, Méndez-Fernandez, Rosalía, Muñoz-Fernández, Santiago, Cordero-Coma, Miguel, Martinez-Costa, Lucia, Valls, Elia, Reyes, Miguel, Francisco, Félix, Esteban, Mar, Fonollosa, Alex, Sanchez-Alonso, Fernando, Fernández-Espartero, Cruz, Diaz-Valle, Teresa, Carrasco, José Miguel, Beltran-Catalán, Emma, Hernández-Garfella, Marisa, Hernández, María Victoria, Pelegrin, Laura, Blanco, Ricardo, Diaz-Valle, David

“…To develop a disease activity index for patients with uveitis (UVEDAI) encompassing the relevant domains of disease activity considered important among experts…”
Get full text

The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study by Santos-Gómez, Montserrat, Calvo-Río, Vanesa, Blanco, Ricardo, Beltrán, Emma, Mesquida, Marina, Adán, Alfredo, Cordero-Coma, Miguel, García-Aparicio, Ángel M, Valls Pascual, Elia, Martínez-Costa, Lucía, Hernández, María Victoria, Hernandez Garfella, Marisa, González-Vela, María C, Pina, Trinitario, Palmou-Fontana, Natalia, Loricera, Javier, Hernández, José L, González-Gay, Miguel A

“…To assess the efficacy of other biologic therapies, different from infliximab (IFX) and adalimumab (ADA), in patients with Behçet's disease uveitis (BU)…”
Get full text

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases by Atienza‐Mateo, Belén, Martín‐Varillas, José Luis, Calvo‐Río, Vanesa, Demetrio‐Pablo, Rosalía, Beltrán, Emma, Sánchez‐Bursón, Juan, Mesquida, Marina, Adan, Alfredo, Hernández, María Victoria, Hernández‐Garfella, Marisa, Valls‐Pascual, Elia, Martínez‐Costa, Lucía, Sellas‐Fernández, Agustí, Cordero‐Coma, Miguel, Díaz‐Llopis, Manuel, Gallego, Roberto, García‐Serrano, José L., Ortego‐Centeno, Norberto, Herreras, José M., Fonollosa, Alejandro, Garcia‐Aparicio, Ángel M., Maíz‐Alonso, Olga, Blanco, Ana, Torre‐Salaberri, Ignacio, Fernandez‐Espartero, Cruz, Jovaní, Vega, Peiteado, Diana, Pato, Esperanza, Cruz, Juan, Férnandez‐Cid, Carlos, Aurrecoechea, Elena, García‐Arias, Miriam, Castañeda, Santos, Caracuel‐Ruiz, Miguel A., Montilla‐Morales, Carlos A., Atanes‐Sandoval, Antonio, Francisco, Félix, Insua, Santos, González‐Suárez, Senen, Sanchez‐Andrade, Amalia, Gamero, Fernando, Linares Ferrando, Luis F., Romero‐Bueno, F., García‐González, A. Javier, González, Raquel Almodóvar, Muro, Enrique Minguez, Carrasco‐Cubero, Carmen, Olive, Alejandro, Prior, Águeda, Vázquez, Julio, Ruiz‐Moreno, Oscar, Jiménez‐Zorzo, Fernando, Manero, Javier, Muñoz Fernandez, Santiago, Fernández‐Carballido, Cristina, Rubio‐Romero, Esteban, Pages, Fred Antón, Toyos‐Sáenz de Miera, Francisco J., Martinez, Myriam Gandia, Díaz‐Valle, David, López Longo, Francisco J., Nolla, Joan M., Álvarez, Enrique Raya, Martínez, Marcelino Revenga, González‐López, Julio José, Rodríguez‐Cundin, Paz, Hernández, José L., González‐Gay, Miguel A., Blanco, Ricardo

“…Objective To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first‐line biologic drug over 1 year of treatment in a large series of…”
Get full text

Rare association between Vogt–Koyanagi–Harada disease and rheumatoid arthritis: Report of a clinical case from the unit of multidisciplinary uveitis by Paz-Solarte, Juan Alberto, Hernández-Garfella, Marisa, Rueda-Cid, Amalia, Campos-Fernández, Cristina, Calvo-Catala, Javier

Get full text

SER recommendations for the treatment of uveitis by Beltrán Catalán, Emma, Brito García, Noé, Pato Cour, Esperanza, Muñoz Fernández, Santiago, Gómez Gómez, Alejandro, Díaz Valle, David, Hernández Garfella, Marisa, Francisco Hernández, Félix Manuel, Trujillo Martín, M Del Mar, Silva Fernández, Lucía, Villanueva, Gemma, Suárez Cuba, Julio, Blanco, Ricardo

“…To develop evidence-based expert-consensus recommendations for the management of non-infectious, non-neoplastic, non-demyelinating disease associated uveitis…”
Get full text

Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients by Martín-Varillas, José Luis, Sanchez-Bilbao, Lara, Calvo-Río, Vanesa, Adán, Alfredo, Hernanz, Inés, Gallego-Flores, Adela, Beltran-Catalan, Emma, Castro-Oreiro, Sonia, Fanlo, Patricia, Garcia Martos, Alvaro, Torre, Ignacio, Cordero-Coma, Miguel, De Dios, Juan Ramon, García-Aparicio, Ángel, Hernández-Garfella, Marisa, Sánchez-Andrade, Amalia, García-Valle, Andrea, Maiz, Olga, Miguélez, Roberto, Rodríguez-Montero, Sergio, Urruticoechea, Ana, Veroz, Raúl, Conesa, Arantxa, Fernández-Carballido, Cristina, Jovaní, Vega, Mondejar, Jose J, Martínez González, Olga, Moya Alvarado, Patricia, Romero-Yuste, Susana, Rubio-Muñoz, Paula, Peña-Sainz-Pardo, Eva, Garijo-Bufort, Marta, Demetrio-Pablo, Rosalía, Hernández, José L, Blanco, Ricardo

“…ObjectivesTo evaluate effectiveness and safety of certolizumab pegol (CZP) in uveitis due to immune-mediated inflammatory diseases (IMID).MethodsMulticentre…”
Get full text

Recomendaciones SER sobre el tratamiento de la uveítis by Beltrán Catalán, Emma, Brito García, Noé, Pato Cour, Esperanza, Muñoz Fernández, Santiago, Gómez Gómez, Alejandro, Díaz Valle, David, Hernández Garfella, Marisa, Francisco Hernández, Félix Manuel, Trujillo Martín, M. del Mar, Silva Fernández, Lucía, Villanueva, Gemma, Suárez Cuba, Julio, Blanco, Ricardo

“…Elaborar recomendaciones basadas en la evidencia disponible y el consenso de expertos para el manejo terapéutico de los pacientes con uveítis no infecciosas,…”
Get full text

Rara asociación entre la enfermedad de Vogt-Koyanagi-Harada y la artritis reumatoide. Reporte de un caso clínico de la consulta multidisciplinar de uveítis by Paz-Solarte, Juan Alberto, Hernández-Garfella, Marisa, Rueda-Cid, Amalia, Campos-Fernández, Cristina, Calvo-Catala, Javier

Get full text

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease by Martín-Varillas, José Luis, Calvo-Río, Vanesa, Beltrán, Emma, Sánchez-Bursón, Juan, Mesquida, Marina, Adán, Alfredo, Hernandez, María Victoria, Garfella, Marisa Hernández, Pascual, Elia Valls, Martínez-Costa, Lucía, Sellas-Fernández, Agustí, Cordero-Coma, Miguel, Díaz-Llopis, Manuel, Gallego, Roberto, Salom, David, Ortego, Norberto, García-Serrano, José L., Callejas-Rubio, José-Luis, Herreras, José M., García-Aparicio, Ángel, Maíz, Olga, Blanco, Ana, Torre, Ignacio, Díaz-Valle, David, Pato, Esperanza, Aurrecoechea, Elena, Caracuel, Miguel A., Gamero, Fernando, Minguez, Enrique, Carrasco-Cubero, Carmen, Olive, Alejandro, Vázquez, Julio, Ruiz-Moreno, Oscar, Manero, Javier, Muñoz-Fernández, Santiago, Martinez, Myriam Gandía, Rubio-Romero, Esteban, Toyos-Sáenz de Miera, F. Javier, López Longo, Francisco Javier, Nolla, Joan M., Revenga, Marcelino, González-Vela, Carmen, Loricera, Javier, Atienza-Mateo, Belén, Demetrio-Pablo, Rosalía, Hernández, José Luis, González-Gay, Miguel A., Blanco, Ricardo

“…To assess efficacy, safety, and cost-effectiveness of adalimumab (ADA) therapy optimization in a large series of patients with uveitis due to Behçet disease…”
Get full text

Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group by Llorenç, Victor, Cordero-Coma, Miguel, Blanco-Esteban, Ana, Heras-Mulero, Henar, Losada-Castillo, María-José, Jovani-Casano, Vega, Valls-Pascual, Elia, Jodar-Marquez, Margarita, García-Aparicio, Ángel, Fonollosa, Alejandro, González-Guijarro, Juan Jacobo, Rodriguez-Melian, Luís, Fernández-Prada, Manuel, Jerez-Fidalgo, María, Hernandez-Garfella, Marisa, Esquinas, Cristina, Sainz-de-la-Maza, Maite, Adán, Alfredo

“…To study the drug retention rate (DRR), causes, and predictors of discontinuation of adalimumab (ADA) in a real-world uveitis setting. Multicentric,…”
Get full text

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients by Calvo-Río, Vanesa, Blanco, Ricardo, Beltrán, Emma, Sánchez-Bursón, Juán, Mesquida, Marina, Adán, Alfredo, Hernandez, María Victoria, Hernandez Garfella, Marisa, Valls Pascual, Elia, Martínez-Costa, Lucía, Sellas-Fernández, Agustí, Cordero Coma, Miguel, Díaz-Llopis, Manuel, Gallego, Roberto, Salom, David, García Serrano, José L, Ortego, Norberto, Herreras, José M, Fonollosa, Alejandro, García-Aparicio, Angel M, Maíz, Olga, Blanco, Ana, Torre, Ignacio, Fernández-Espartero, Cruz, Jovani, Vega, Peiteado-Lopez, Diana, Pato, Esperanza, Cruz, Juan, Fernández-Cid, Carlos, Aurrecoechea, Elena, García, Miriam, Caracuel, Miguel A, Montilla, Carlos, Atanes, Antonio, Hernandez, Félix Francisco, Insua, Santos, González-Suárez, Senén, Sánchez-Andrade, Amalia, Gamero, Fernando, Linares, Luis, Romero-Bueno, Fredeswinda, García, A Javier, Almodovar, Raquel, Minguez, Enrique, Carrasco Cubero, Carmen, Olive, Alejandro, Vázquez, Julio, Ruiz Moreno, Oscar, Jiménez-Zorzo, Fernando, Manero, Javier, Muñoz Fernández, Santiago, Rueda-Gotor, Javier, González-Gay, Miguel A

“…The aim of this study was to assess the efficacy of anti-TNF-α therapy in refractory uveitis due to Behçet's disease (BD). We performed a multicentre study of…”
Get full text

Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis by Llorenç, Victor, Cordero-Coma, Miguel, Blanco-Esteban, Ana, Heras-Mulero, Henar, Losada-Castillo, María-José, Jovani-Casano, Vega, Valls-Pascual, Elia, Jodar-Marquez, Margarita, García-Aparicio, Ángel, Fonollosa, Alejandro, González-Guijarro, Juan Jacobo, Rodriguez-Melian, Luís, Fernández-Prada, Manuel, Jerez-Fidalgo, María, Hernandez-Garfella, Marisa, Esquinas, Cristina, Sainz-de-la-Maza, Maite, Adán, Alfredo

“…To study the drug retention rate (DRR), causes, and predictors of discontinuation of adalimumab (ADA) in a real-world uveitis setting. Multicentric,…”
Get full text